Mechanism-based modeling of the clinical effects of bevacizumab and everolimus on vestibular schwannomas of patients with neurofibromatosis type 2

  1. Ouerdani, A.
  2. Goutagny, S.
  3. Kalamarides, M.
  4. Trocóniz, I.F.
  5. Ribba, B.
Journal:
Cancer Chemotherapy and Pharmacology

ISSN: 1432-0843,  0344-5704

Year of publication: 2016

Volume: 77

Issue: 6

Pages: 1263-1273

Type: Article

DOI: 10.1007/S00280-016-3046-2 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus